We could not find any results for:
Make sure your spelling is correct or try broadening your search.
The current PAHC market cap is 878.52M. The company's latest EPS is USD 0.0596 and P/E is 363.93.
Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Revenue | 255.05M | 231.35M | 249.94M | 263.22M | 273.16M |
Operating Income | 23.77M | -726k | 15.7M | 19.92M | 18.42M |
Net Income | 11.5M | -8.02M | 1.27M | 8.41M | 752k |
Year End 30 June 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Revenue | 800.35M | 833.35M | 942.26M | 977.89M | 1.02B |
Operating Income | 69.19M | 74.87M | 78.99M | 71.85M | 53.32M |
Net Income | 33.55M | 54.39M | 49.18M | 32.61M | 2.42M |
Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Assets | 971.4M | 964.52M | 972.71M | 979.04M | 982.18M |
Total Liabilities | 688.89M | 691.45M | 701.91M | 708.94M | 725.54M |
Total Equity | 282.51M | 273.07M | 270.8M | 270.09M | 256.64M |
Year End 30 June 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Assets | 784.1M | 841.33M | 931.7M | 971.4M | 982.18M |
Total Liabilities | 595.9M | 602.8M | 669.26M | 688.89M | 725.54M |
Total Equity | 188.2M | 238.53M | 262.44M | 282.51M | 256.64M |
Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Operating | 13.31M | 16.2M | 47.76M | 59.17M | 87.59M |
Investing | -74.02M | -15.35M | -40.21M | -39.08M | -48.19M |
Financing | 26.99M | 1.3M | -13.41M | -8.56M | -6.77M |
Year End 30 June 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Operating | 59.35M | 48.31M | 31.65M | 13.31M | 87.59M |
Investing | -120.39M | -18.58M | -22.58M | -74.02M | -48.19M |
Financing | 40.94M | -17M | 16.34M | 26.99M | -6.77M |
Market Cap | 878.52M |
Price to Earnings Ratio | 363.93 |
Price to Sales Ratio | 0.86 |
Price to Cash Ratio | 12.44 |
Price to Book Ratio | 3.42 |
Dividend Yield | 2.21% |
Shares Outstanding | 40.5M |
Average Volume (1 week) | 174.92k |
Average Volume (1 Month) | 147.36k |
52 Week Change | 86.98% |
52 Week High | 25.98 |
52 Week Low | 10.035 |
Spread (Intraday) | 8.36 (29.86%) |
Company Name | Phibro Animal Health Corporation |
Address |
111 8th avenue new york 10011 |
Website | https://www.pahc.com |
Industry | gen farms-lvstk, animal spec (0291) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions